Butyrate ameliorates quinolinic acid–induced cognitive decline in obesity models
Journal of Clinical Investigation · 15.02.2023 · 133 (4)
DOI: 10.1172/jci154612 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 15.02.2023. Verfasst von Xing Ge und 17 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of Immunity and Metabolism, Jiangsu International Laboratory of Immunity and Metabolism, Department of Pathogen Biology and Im…. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Cognitive Dysfunction. Die Arbeit wurde bisher 119-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of the Jiangsu Higher Education Institutions of China, Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) in 2014.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangsu Key Laboratory of Immunity and Metabolism, Jiangsu International Laboratory of Immunity and Metabolism, Department of Pathogen Biology and Immunology, Xuzhou Medical University, Jiangsu, China.
- Department of Neurology, Affiliated Hospital of Xuzhou Medical University, Jiangsu, China.
- Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning, China.
- The Second Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning, China.
- Illawarra Health and Medical Research Institute (IHMRI) and School of Medical, Indigenous, and Health, University of Wollongong, New South Wales, Australia.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of the Jiangsu Higher Education Institutions of China
- Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) in 2014
- Starting Foundation for Talents of Xuzhou Medical University
- Post‑graduate Research & Practice Innovation Program of Jiangsu Province
Zitieren
APA
Ge, X., Zheng, M., Hu, M., Fang, X., Geng, D., Liu, S., Wang, L., Zhang, J., Guan, L., Zheng, P., Xie, Y., Pan, W., Zhou, M., Zhou, L., Tang, R., Zheng, K., Yu, Y., & Huang, X. F. (2023). Butyrate ameliorates quinolinic acid–induced cognitive decline in obesity models. Journal of Clinical Investigation, 133(4). https://doi.org/10.1172/jci154612
Vancouver
Ge X, Zheng M, Hu M, Fang X, Geng D, Liu S, et al. Butyrate ameliorates quinolinic acid–induced cognitive decline in obesity models. Journal of Clinical Investigation. 2023;133(4). doi:10.1172/jci154612
BibTeX
@article{Ge2023,
author = {Ge, Xing and Zheng, Mingxuan and Hu, Minmin and Fang, Xiaoli and Geng, Deqin and Liu, Sha and Wang, Li and Zhang, Jun and Guan, Li and Zheng, Peng and Xie, Yuanyi and Pan, Wei and Zhou, Menglu and Zhou, Limian and Tang, Renxian and Zheng, Kuiyang and Yu, Yinghua and Huang, Xu-Feng},
title = {Butyrate ameliorates quinolinic acid–induced cognitive decline in obesity models},
journal = {Journal of Clinical Investigation},
year = {2023},
volume = {133},
number = {4},
doi = {10.1172/jci154612}
}
EUVIMED